BioSpace News Archive

International medical imaging IT and cybersecurity company Sectra noted sales growth and increased operating profit for the six-month period.

Oncopeptides AB, a biotech company focused on research and development of therapies for difficult-to-treat hematological diseases, announces that the company will present three posters on melflufen at the Annual American Society of Hematology Meeting, ASH, on December 11-14, in Atlanta, Georgia, USA.

BeiGene announced results from the RATIONALE 309 trial of tislelizumab versus placebo in combination with chemotherapy as a first-line treatment for patients with recurrent or metastatic nasopharyngeal cancer at the European Society for Medical Oncology Immuno-Oncology Congress 2021, taking place on December 8-11, 2021.